Tender detail
Heparin sodium II
Summary
The Institute for Clinical and Experimental Medicine is procuring injectable medicinal products containing heparin sodium (ATC B01AB01) to treat patients for the approved indications in the Summary of Product Characteristics in force on the bid submission date. The procurement comprises one lot, with an estimated value of CZK 41,786,000 and a planned duration of 48 months. Delivery is for the Institute in Prague.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.